HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Shigeru Kinoshita Selected Research

Y 27632

9/2015Effect of the Rho Kinase Inhibitor Y-27632 on Corneal Endothelial Wound Healing.
4/2013The ROCK inhibitor eye drop accelerates corneal endothelium wound healing.
1/2012A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma.
7/2011Enhancement of corneal endothelium wound healing by Rho-associated kinase (ROCK) inhibitor eye drops.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Shigeru Kinoshita Research Topics

Disease

23Inflammation
02/2015 - 02/2003
19Stevens-Johnson Syndrome
10/2015 - 10/2002
10Glaucoma
11/2015 - 09/2002
10Toxic Epidermal Necrolysis (Lyell's Syndrome)
10/2015 - 02/2007
9Cataract (Cataracts)
09/2015 - 09/2003
6Infection
07/2015 - 06/2004
6Cicatrix (Scar)
07/2015 - 08/2004
5Open-Angle Glaucoma (Glaucoma, Open Angle)
07/2015 - 03/2006
5Neoplasms (Cancer)
01/2014 - 03/2010
5Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
09/2013 - 02/2009
5Wounds and Injuries (Trauma)
12/2012 - 01/2008
5Keratitis
08/2011 - 10/2002
4Keratoconjunctivitis
11/2015 - 06/2009
4Corneal Edema
09/2015 - 03/2006
4Eye Diseases (Eye Disease)
03/2014 - 10/2012
3Uveitis
09/2015 - 06/2005
3Exfoliation Syndrome
06/2015 - 06/2007
3Astigmatism
06/2015 - 08/2010
3Corneal Opacity
01/2015 - 04/2004
3Sarcoidosis (Schaumann Disease)
11/2012 - 06/2005
3Diabetic Retinopathy (Retinopathy, Diabetic)
10/2012 - 01/2003
3Macular Degeneration (Age-Related Maculopathy)
08/2012 - 09/2002
3Hypersensitivity (Allergy)
01/2010 - 02/2004
2Skin Diseases
02/2015 - 02/2014
2Contact Dermatitis (Eczema, Contact)
02/2015 - 02/2014
2Edema
11/2014 - 04/2013
2Eye Pain
03/2014 - 06/2013
2Foreign Bodies (Foreign Body)
03/2014 - 06/2013
2Photophobia (Light Sensitivity)
03/2014 - 12/2012
2Macular Edema
06/2012 - 08/2005
2Blindness (Hysterical Blindness)
05/2012 - 07/2006
2Burns
04/2012 - 11/2005
2Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid)
01/2012 - 11/2005
2Entropion
08/2011 - 08/2011
2Amyloid Plaque
03/2010 - 03/2007
2Corneal Neovascularization
02/2010 - 05/2005
2Angle-Closure Glaucoma (Glaucoma, Angle Closure)
06/2007 - 01/2007
2Ulcer
11/2005 - 09/2003
1Ocular Hypertension (Glaucoma, Suspect)
11/2015
1Corneal Perforation
11/2015
1Rheumatoid Arthritis
09/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
09/2015
1Congenital Abnormalities (Deformity)
07/2015
1Allergic Contact Dermatitis
02/2015
1Eyelid Diseases
01/2015

Drug/Important Bio-Agent (IBA)

9Ophthalmic Solutions (Eye Drops)IBA
09/2015 - 04/2006
7HLA-A Antigens (HLA-A)IBA
10/2015 - 04/2002
5Toll-Like Receptor 3IBA
02/2015 - 07/2007
5latanoprost (Xalatan)FDA Link
01/2015 - 09/2002
5rebamipideIBA
03/2014 - 12/2012
5Interleukin-8 (Interleukin 8)IBA
01/2014 - 04/2004
5CytokinesIBA
09/2013 - 02/2003
4Y 27632IBA
09/2015 - 07/2011
4HLA-B Antigens (HLA-B)IBA
01/2014 - 11/2008
4CalciumIBA
12/2012 - 03/2010
4Retinaldehyde (Retinal)IBA
10/2012 - 08/2003
4Messenger RNA (mRNA)IBA
01/2012 - 04/2006
4DNA (Deoxyribonucleic Acid)IBA
02/2008 - 09/2003
4Interleukin-6 (Interleukin 6)IBA
09/2004 - 07/2003
3Immunoglobulin E (IgE)IBA
01/2014 - 08/2008
3gelatinous drop-like Corneal dystrophyIBA
12/2012 - 09/2010
3EP3 Subtype Prostaglandin E ReceptorsIBA
11/2012 - 12/2010
3Dexamethasone (Maxidex)FDA LinkGeneric
08/2004 - 12/2002
2Anti-Bacterial Agents (Antibiotics)IBA
11/2015 - 12/2012
2Biological Markers (Surrogate Marker)IBA
10/2015 - 11/2013
2Carbamazepine (Tegretol)FDA LinkGeneric
10/2015 - 12/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2015 - 12/2012
2AntigensIBA
02/2015 - 06/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2014 - 01/2011
2Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
01/2014 - 01/2008
2Aminocaproic Acids (EAC)FDA LinkGeneric
09/2013 - 02/2009
2Dinoprostone (PGE2)FDA Link
09/2013 - 11/2012
2VancomycinFDA LinkGeneric
01/2013 - 10/2002
2SteroidsIBA
12/2010 - 06/2004
2Toll-Like Receptors (Toll-Like Receptor)IBA
09/2010 - 07/2007
2Proteins (Proteins, Gene)IBA
03/2010 - 08/2005
2Adrenal Cortex Hormones (Corticosteroids)IBA
06/2009 - 09/2003
2Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2008 - 06/2006
2AlkaliesIBA
11/2005 - 02/2003
2NF-kappa B (NF-kB)IBA
02/2005 - 09/2004
2HLA-DR Antigens (HLA-DR)IBA
07/2003 - 04/2002
1Protein Kinases (Protein Kinase)IBA
11/2015
1Methotrexate (Mexate)FDA LinkGeneric
09/2015
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
09/2015
1betaglycan (TGFBR3)IBA
07/2015
1CosmeticsIBA
07/2015
1corrigendumIBA
06/2015
1Picryl Chloride (Trinitrochlorobenzene)IBA
02/2015
1bimatoprost (Lumigan)FDA Link
01/2015
1Timolol (Blocadren)FDA LinkGeneric
01/2015

Therapy/Procedure

9Transplantation (Transplant Recipients)
04/2012 - 06/2004
5Corneal Transplantation (Keratoplasty)
11/2015 - 10/2002
5Transplants (Transplant)
07/2015 - 05/2005
3Intraocular Lenses (Intraocular Lens)
06/2015 - 08/2010
2Intravitreal Injections
08/2012 - 01/2011
2Penetrating Keratoplasty
05/2012 - 08/2009
2Phacoemulsification
09/2011 - 08/2010
2Sutures (Suture)
08/2011 - 03/2003
2Trabeculectomy (Trabeculoplasty)
01/2007 - 08/2004
1Solid-State Lasers
06/2015